DCTH

Delcath Systems, Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$14.04Close $487.1MMarket cap $8.19 – $17.3652-week range Nov 9, 2026Next report · before the open

Highlights

Strengths

  • Leading the market RS 82 · stronger than 82% of stocks over 12 months

Cautions

  • Trend not confirmed 7 of 8 conditions · under the 50-day
  • Results soon Nov 9, 2026, in 8 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 19%
1wk down 2.6% price change
1mo down 12.1% price change
12-month return up 49% market up 11% · its own up 34%
F-score 7 / 9 Strong
Altman Z 19.32 Low risk
P/E 180.4× price / earnings
PEG — P/E / EPS growth
P/B 4.4× price / book
Earnings yield up 0.1% EBIT / enterprise value
Cheaper than 41% of the market · around average
Revenue growth up 129% year on year
EPS growth 0% latest quarter · +210 pts
Sales growth up 21% latest quarter · -6 pts
ROE up 3% return on equity
Free cash margin up 25% $21.0M FCF
D/E — long-term debt / equity
Net debt / EBITDA -65.8× net cash
Interest cover —EBIT / interest
Piotroski tests
  • short-term liquidity weakened
  • issued more shares
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • reduced long-term debt
  • gross margin widened
  • assets working harder

Repair signals

  • FCF turned positive ($-19M → $21M)
  • Gross margin 83.4% → 86.2%

Trade setup

ATR% 3.9% $0.55 a day · 2×ATR $12.95
RS 82 / 99 vs the universe
Trend 7 / 8 under the 50-day
Relative volume 1.2× vs 50-day average
Up/down volume 0.91 50 sessions
Implied move — no option chain · report Nov 9, 2026
Trend template · 7 of 8
  • Price above the 50-day average: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Shareholders diluted The share count rose 4.9% over the year, from 33m to 35m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported Aug 6, 2026
Results reaction Aug 6, 2026+19% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $85.2M +129% on FY2024
$0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 FY2021 · $3.6M FY2022 · $2.7M FY2023 · $2.1M FY2024 · $37.2M FY2025 · $85.2M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $2.7M back to a profit
-$50M $0 FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$24.2M FY2021 · -$25.6M FY2022 · -$36.5M FY2023 · -$47.7M FY2024 · -$26.4M FY2025 · $2.7M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $21.0M back to a profit
-$50M $0 $25M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$23.6M FY2021 · -$22.7M FY2022 · -$25.2M FY2023 · -$31.3M FY2024 · -$19.2M FY2025 · $21.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 86%
  • Net 3%
  • Free cash 25%
-2500% 0% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 FY2021 · Gross 81% · Net -721% · Free cash -640% FY2022 · Gross 75% · Net -1343% · Free cash -925% FY2023 · Gross 69% · Net -2309% · Free cash -1516% FY2024 · Gross 83% · Net -71% · Free cash -52% FY2025 · Gross 86% · Net 3% · Free cash 25%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $28.6M FY2021 · Cash $22.8M · Long-term debt $5.0M FY2022 · Cash $7.7M · Long-term debt $15.7M FY2023 · Cash $12.6M · Long-term debt $10.2M FY2024 · Cash $32.4M · Long-term debt $0 FY2025 · Cash $43.5M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 34.69m +478.6% since FY2020
34.69m 6m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 6m FY2021 · 7.91m FY2022 · 10.05m FY2023 · 22.76m FY2024 · 33.06m FY2025 · 34.69m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue — $3.6M $2.7M $2.1M $37.2M $85.2M
Gross margin — 81% 75% 69% 83% 86%
Operating income -$21.3M -$24.5M -$33.9M -$38.2M -$12.4M $660,000
Net income -$24.2M -$25.6M -$36.5M -$47.7M -$26.4M $2.7M
Net margin — -721% -1343% -2309% -71% 3%
Earnings per share -$8.34 -$3.59 -$4.12 -$2.94 -$0.93 $0.07
Free cash flow -$23.6M -$22.7M -$25.2M -$31.3M -$19.2M $21.0M
Free cash margin — -640% -925% -1516% -52% 25%
Cash $28.6M $22.8M $7.7M $12.6M $32.4M $43.5M
Long-term debt — $5.0M $15.7M $10.2M $0 —
Shareholders' equity $22.1M $12.0M -$5.9M $15.8M $68.7M $111.2M
Shares outstanding 6m 7.91m 10.05m 22.76m 33.06m 34.69m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 7, 2026 Quarterly ↗ Mar 31, 2026 37d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Nov 4, 2025 Quarterly ↗ Sep 30, 2025 35d
Aug 6, 2025 Quarterly ↗ Jun 30, 2025 37d
May 8, 2025 Quarterly ↗ Mar 31, 2025 38d
Mar 6, 2025 Annual ↗ Dec 31, 2024 65d
Nov 8, 2024 Quarterly ↗ Sep 30, 2024 39d
Aug 5, 2024 Quarterly ↗ Jun 30, 2024 36d
May 14, 2024 Quarterly ↗ Mar 31, 2024 44d
Mar 26, 2024 Annual ↗ Dec 31, 2023 86d
Nov 13, 2023 Quarterly ↗ Sep 30, 2023 44d

Current reports